Results of a 12-month, multicenter, randomized trial of Everolimus with reduced-exposure Cyclosporine vs. MMF and standard-exposure Cyclosporine in de-novo cardiac transplant recipients

Lehmkuhl H

Arizon J

Viganò M

LIVI, Ugolino